<DOC>
	<DOCNO>NCT01832753</DOCNO>
	<brief_summary>The purpose research study learn effect treat subclinical hypothyroidism ( SCH ) thyroid hormone replacement child adolescents Down syndrome ( DS ) . We hypothesize treatment SCH thyroid hormone replacement improve cardiometabolic health quality life .</brief_summary>
	<brief_title>Treatment Trial Subclinical Hypothyroidism Down Syndrome</brief_title>
	<detailed_description>The American Academy Pediatrics ( AAP ) recommend yearly screen thyroid study DS . Clinical experience suggest TSH concentration subclinical hypothyroid range ( 5-10 milli international unit ( mIU/L ) ) uncommon DS , benefit risk treat SCH DS population know . In adult , SCH associate increase cardiometabolic risk ( CMR ) individual DS may increase cardiometabolic risk well . Data child SCH limit . Despite recommendation screen thyroid dysfunction , evidence guide management elevate TSH child DS equally sparse . In non-DS child , TSH &gt; 4.65 mIU/L associate low HDL . One year levothyroxine treatment short child subclinical hypothyroidism short stature improve growth velocity . Left ventricular ( LV ) function LV mass ( echocardiography ) different 16 child DS subclinical hypothyroidism ( TSH &gt; 6.5 mIU/L ; mean TSH = 7.8 mIU/L ) vs. 25 child DS normal TSH . However , finding may limit small sample size . An intervention study 7 subject age 2-42 year DS hypothyroidism , define low T4 normal elevate TSH ( 0.2-18.9 mIU/L ) 8 week levothyroxine treatment improve developmental functional outcome . Anthropometrics CMR factor examine . In contrast , increase TSH absence overt congenital hypothyroidism common neonate DS prompt randomize control trial ( RCT ) 181 neonate DS . TSH-directed levothyroxine treatment associate well growth , weight gain , motor development 24 month compare placebo . These finding highlight `` asymptomatic '' component subclinical hypothyroidism may medically-relevant effect . This study provide potentially clinically relevant preliminary evidence treatment subclinical hypothyroidism DS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Males female , age 8 20 year Diagnosis Down syndrome Subclinical hypothyroidism : TSH level 5 10 mIU/L , normal T4 Parental/guardian permission ( informed consent ) appropriate , child assent Females least 11 year age menarchal must negative urine/serum pregnancy test Committed adherence levothyroxine treatment study completion Pregnancy Type 1/Type 2 diabetes Chronic medical condition medication use affect growth , nutrition , blood glucose , insulin secretion , thyroid function ( lithium certain seizure medication ) Current use levothyroxine antithyroid hormone Cyanotic congenital heart disease , pulmonary hypertension ( describe last echo report subject CHD ) , congenital heart disease consider medically unstable study cardiologist</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>subclinical hypothyroidism</keyword>
	<keyword>thyroid</keyword>
	<keyword>levothyroxine</keyword>
</DOC>